advertisement

Topcon

Ferraro V 11

Showing records 1 to 11 | Display all abstracts from Ferraro V

128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Di Maria A
Clinical Ophthalmology 2025; 19: 2383-2391
127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Ferraro V
Clinical Ophthalmology 2025; 19: 2295-2303
128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Ferraro V
Clinical Ophthalmology 2025; 19: 2383-2391
127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Gaeta A
Clinical Ophthalmology 2025; 19: 2295-2303
128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Barone G
Clinical Ophthalmology 2025; 19: 2383-2391
127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Barone G; Confalonieri F
Clinical Ophthalmology 2025; 19: 2295-2303
128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Vitali M; Tredici C
Clinical Ophthalmology 2025; 19: 2383-2391
127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Tredici C
Clinical Ophthalmology 2025; 19: 2295-2303
128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Gaeta A
Clinical Ophthalmology 2025; 19: 2383-2391
127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Vinciguerra P; Di Maria A
Clinical Ophthalmology 2025; 19: 2295-2303
128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Vinciguerra P; Confalonieri F
Clinical Ophthalmology 2025; 19: 2383-2391

Issue 25-3

Change Issue


advertisement

WGA Rescources